Brief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
BRIEF-Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System Oct 19 (Reuters) - Haemonetics Corp HAE.N:
HAEMONETICS ANNOUNCES FDA APPROVAL OF PERQSEAL® ELITE VASCULAR CLOSURE SYSTEM
Source text: ID:nPn7tw4SHa
Further company coverage: HAE.N
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices